United Therapeutics (UTHR) reported $748.9 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 22.9%. EPS of $6.39 for the same period compares to $5.38 a year ago.The reported revenue represents a surprise of +4.38% over the Zacks Consensus Estimate of $717.49 million. With the consensus EPS estimate being $6.18, the EPS surprise was +3.40%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare ...